Cite

HARVARD Citation

    Cui, M. et al. (2016). A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China. Advances in therapy. 33 (9), pp. 1600-1611. [Online]. 
  
Back to record